Instil Bio shares are trading higher after HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $25 to $40.
Portfolio Pulse from Benzinga Newsdesk
Instil Bio shares surged after HC Wainwright & Co reiterated a Buy rating and increased the price target from $25 to $40.
September 12, 2024 | 2:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Instil Bio's stock price increased following HC Wainwright & Co's decision to maintain a Buy rating and raise the price target to $40.
The increase in price target from $25 to $40 by a reputable firm like HC Wainwright & Co is a strong positive signal for investors, likely leading to increased buying interest and a rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100